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Book Reviews
Urological Oncology - Dilemmas and Developments, Edited by
J. Waxman & G. Williams, Sevenoaks, Kent: Edward
Arnold, 1992, 252 pp. £49.50.
I am always somewhat wary of books based on conferences
and when only some of the editors contribute chapters. Since
the conference was in 1988, the first puzzle is to why it has
taken so long to get into print and this remains the main
problem of this book. It is a mid-1980s view of urological
cancer.
The four main urological tumours are assessed separately
and a very clinical approach has been taken. There is
therefore no room for the advances in understanding some of
these tumours at the molecular level, nor any discussion as to
the potential value of screening in prostate cancer, for exam-
ple. Although the routine management of renal cancer has
not changed, the role of interleukin-2 (if any) has not been
really explored in this book. The chapters on bladder cancer
are generally better (and more up to date), especially that by
Yagoda on chemotherapy, but there is no real debate as the
roles of radical surgery versus radical radiotherapy in muscle
invasive bladder cancer. The prostate section has the greatest
omissions since only advanced disease is discussed and there
is no mention of radical surgery or radiotherapy for patients
with early disease. Testicular cancer gets a better coverage,
although the only chapters which stand out are by Donohue
on the controversy of retroperitoneal lymphadenopathy ver-
sus surveillance in early stage disease and by Horwich on the
identification of patients with good and bad risk metastatic
teratoma.
This book shows some of the steady progress being made
in the management of urological cancer and it suffers as a
result of continued progress since it only patchily reflects
1980s practice. This book may be a tribute to the late
Professor Bloom but it is not a valuable addition to any
departmental library in 1992.
P.I. Clark
Environmental Tobacco Smoke and Mortality
P.N. Lee, Switzerland: Karger, 1992, 224 pp. £77.40
Expert comittees in various countries, including the Indepen-
dent Scientific Committee on Smoking and Health in the
UK, have systematically examined the evidence on passive
smoking and health and concluded that there is definite
hazard. The issue has also been tested in a court case in
Australia, where the judge ruled against the tobacco industry
in their defence of an advertised statement that the evidence
linking passive smoking and disease was inconclusive.
Nobody denies, however, that the absolute risk associated
with environmental tobacco smoke is small: for lung cancer it
is estimated to be the equivalent of actively smoking one-fifth
of a cigarette per day.
P.N. Lee, the author of the above newly published book,
has for many years been arguing that there is no hazard, and
this book presents his case. The book is not an independent
review by a neutral observer, and it is misleading that the
book does not reveal the author's consultancy to the tobacco
industry.
Apart from the irritant effect of environmental tobacco
smoke - which nobody could reasonably dispute - the
evidence linking passive smoking and disease is considered
conclusive in two areas, respiratory disease in children and
lung cancer in adults. This book does not examine the first
and its case rests largely on the chapter on lung cancer,
examining the group of 29 studies that almost all show an
association. Most people are persuaded by the simple argu-
ment that carcinogens experimentally have no threshold, and
since tobacco smoke causes lung cancer in active smokers it
must also do so at proportionately reduced rick in passive
smokers. The observation that individual studies have shown
a dose-response association, and that non-smokers show
higher levels of biochemical markers to tobacco smoke
exposure if their spouses smoke than if they do not, add
further support. The book offers no case against this argu-
ment, but it disputes the interpretation of the group of 29
case-control and prospective observational studies that have
been used to quantify the risk. It is argued that some of the
studies have design faults and that there have been errors in
the estimates previously used to correct for the fact that
'non-smokers' in any study will include a minority of
smokers who have falsely claimed not to smoke. The book
does not present convincing evidence that there is no effect,
but only that the risk might be smaller than generally
accepted - closer to that of active smoking one-tenth of a
cigarette per day perhaps than one-fifth.
The book goes into enormous detail. There are 74 pages
documenting details of 53 individual studies - reading rather
like a lengthy Medline search. There is a chapter on heart
disease, where none of the committees have claimed a causal
association (because the 'no threshold' argument might not
apply, and the relative risk, even if there were no threshold,
would if proportionate to the relative risk in active smokers
be so tiny that it could not be detected in epidemiological
studies). Two chapters examining associations of passive
smoking with other diseases, like the heart disease chapter,
tend to irritate the reader because they are inappropriately
long in dismissing associations that have never seriously been
proposed - with diseases like breast cancer, brain cancer, and
accidents where there is no evidence for a causal association
with active smoking, and with diseases caused by active
smoking such as pharyngeal, oesophageal and pancreatic
cancer where the direct evidence is far too limited to allow a
conclusion.
Those with a special interest in the disease associations of
environmental tobacco smoke with be familiar with Lee's
arguments, but the book does offer a convenient list of
references and tabulations of the data. For non-specialist
readers, this is not a book that presents a fair and balanced
appraisal of the scientific and medical evidence on passive
smoking.
M.R. Law
A Dictionary of Modern Medicine
J.C. Segen, Carnforth, Lancs: Parthenon, 1991, 800 pp.
£48.00.
As though I don't spend enough time on British Journal of
Cancer matters, I now find myself reviewing a book which is
not of specific relevance to my research interests, but which is
a 'reference book' in the broadest sense. Why? Basically
because when it arrived in the Journal office my editorial
assistant expressed a view that such a volume could be of
great value for our own reference purposes. As reviewers get
to keep the books which they review, there was an
immediately obvious solution. So here we are.
The 'Dictionary of Modern Medicine' is precisely that, an
alphabetical listing of around 12,000 words and terms which
the author, a pathologist, believes are 'integral to the lan-
guage of modern medicine'. There is something of an
American bias to the entry, but not unduly so, and the
entries are unbelievably up to date. Many references to
relevant publications are given and a fair proportion of these
are 1991 papers.
The book is fascinating reading. In its own way it is as
original, exciting and unpredictable as a John Irving novel. It
would be a good choice for the third book for a desert island
castaway. The first page I looked at runs from 'Michaelis -410 BOOK REVIEWS
Menten equation' to 'Microaggregates' - nothing very
exciting there. But between them we have 'Michelin tyre
baby', 'Mickey Finn', 'Mickey Mouse appearance', 'Mickey
Mouse ears', 'Mickey Mouse figures' (see 'Mariners wheel'),
and '"Mickey Mouse" medicine' (a derogatory reference to
non-patient-orientated duties that impact upon physicians'
time). A few pages earlier we learn that 'Love canal' is not a
pseudo-medical term used by tabloid newspapers but, in fact,
a water channel near Niagara Falls, dug in 1892 by William
Love and subsequently used as a dump for toxic waste.
However, for readers who may consider that a little tedious,
it is closely followed by 'Lover's heels' - a comminuted
intra-articular fracture of the os calcis with severe crush
injury to the bones of the foot with major anatomic distor-
tions, described in 'jilted' lovers who jump from major
heights.
I think that my favourite entry of the several hundred that
I've read so far is for the '"Jumping Frenchmen of Maine"
syndrome' - a culture-specific complex that is evoked in the
members of a religious sect paradoxically originating from
Wales and residing in North America, the rites of which
include jumping, rolling on the ground, barking like dogs
and so on until a state of ecstasy is achieved!
How does one go about compiling such a dictionary and
how does one check the accuracy of the entries? I don't
know, but I decided to do an independent check by selecting
40 entries relevant to cancer biology and asking colleagues to
give marks out of ten for accuracy and completeness. The
mean mark was 6.7 which can't be bad. Despite this, how-
ever, there are examples of major inaccuracies. The entry on
'MDR' claims, quite wrongly, that 'MDR gene expression is
amplified in methotrexate resistance'. The entry on 'Tumor
suppressor gene' incorrectly includes NM23, ras and tyrosine
kinase gene on chromosome 3 in the list. 'Doxorubicin' has
two different entries, one out of alphabetical order, and
probably meant to describe 'daunorubicin'! The description
of a 'linear accelerator' states that it emits cobalt-60 irradia-
tion. Clearly, therefore, each entry has not been rigorously
checked by an expert in the field and consequently the reader
should feel obliged to obtain an independent check of the
precise details of the more technical terms. Hopefully such
inaccuracies will be eliminated in future editions as they are
unacceptable in a reference book. Nevertheless, the dic-
tionary does an excellent job of 'pointing the reader in the
right direction'.
This book can be strongly recommended for the shelves of
anyone who considers him or herself to be involved in
'modern medicine'. Not only is it scientifically valuable, it
provides an excellent way of spending the odd spare moment
which can be both instructive and entertaining. I'm glad that
I had the opportunity to review the volume and I'm glad that
it now has a permanent place in the BJC editorial office.
P.R. Twentyman
Prospects for Antisense Nucleic Acid Therapy of Cancer and
AIDS
Edited by E. Wickstrom, New York: Wiley-Liss, 1991,
269 pp. £56.00.
'Prospects for Antisense Nucleic Acid Therapy of Cancer and
AIDS' is definitely a book for those who enjoy good science
fiction. Some of the best storytellers of the antisense field
have been brought together in a single volume to produce a
work which is both entertaining and rich in fantasy. How-
ever, the title is to some extent misleading since a significant
proportion of the book is concerned with dissecting gene
function in cell cultures using antisense approaches to ablate
gene expression, and therapeutic prospects are hardly men-
tioned, if at all. Indeed, some of the chapters would be more
appropriately placed within a treatise on oncogenes, in view
of the fact that the rambling speculations are entirely con-
cerned with the action of the particular oncoprotein and
contain but passing reference to the antisense strategies pur-
ported to have produced the observed effects.
There are 17 chapters in all and topics covered include
antisense RNA, oligodeoxynucleotides and oligodeoxynucleo-
tide analogues, as applied against oncogenes and HIV, novel
oligodeoxynucleotide derivatives, and basic principles of tri-
ple helix forming antigene oligodeoxynucleotides. In addi-
tion, some preliminary pharmacokinetic and toxicological
data are presented. As regards antisense RNA, it would
appear that the only therapeutic prospect for this approach is
in the ex vivo generation of HIV-resistant haemopoietic cells
for reinfusion into the patient. However, a very interesting
chapter by Yokoyama on myc antisense RNA draws atten-
tion to a new mechanism, namely the induction of protein(s)
which inhibit transcription, thereby raising the spectre that
multi-gene related phenotypes might result from application
of the antisense RNA technique if similar promoter elements
in other genes were also to be affected by the factors induced.
A majority of the antisense oligonucleotide chapters are
concerned with the normal phosphodiester structure which
has no therapeutic potential whatsoever, as a consequence of
nuclease sensitivity and poor cell uptake characteristics.
However, three chapters describe results with comparatively
nuclease-resistant phosphorothioate oligodeoxynucleotide
analogues and another chapter deals in detail with resistant
methylphosphonates. In general, the classical antisense oligo-
nucleotide experiment is described, where effects of antisense
oligonucleotides on mRNA, protein, cell growth, or colony
formation, in conjunction with negative sense or nonsense
sequence controls, obviously prove that the antisense oligo-
nucleotides must have entered the cells and hybridised
specifically with the target mRNAs. The editor, in his own
chapter, goes so far as to simply ignore the highly significant
inhibition of c-myc p65 expression induced by his control,
scrambled sequence oligodeoxynucleotide, while another
chapter claims sequence-specific effects for short (8 and 11
base) ras antisense methylphosphonate oligodeoxynucleotide
analogues, which, on the basis of statistical probability alone,
would be expected to recognise a variety of different
mRNAs.
Amazingly, the book contains minimal reference to the
cellular pharmacology of the oligonucleotides themselves.
However, where people have looked at what is happening to
oligonucleotides in cells, extensive degradation of normal
phosphodiester structures has been observed, and, in the case
of fluorescently labelled polyanionic oligonucleotides, the
usual picture has been one of brilliantly glowing endosomes
surrounding a nuclear black hole. On the other hand, Leser-
man et al., in their chapter, report that when membrane
barriers are circumvented by direct intracytoplasmic microin-
jection, oligodeoxynucleotides are rapidly localised within the
nucleus by avid binding to nuclear proteins. So it would
appear that any antisense molecule lucky enough to escape
the endosome before reaching the lysosomal execution
chamber would only have a limited time on the loose to find
its RNA home. Furthermore, how can the specificity of
action against the target mRNA be guaranteed, when the
opportunity exists for comparatively strong interaction with
non-targeted nucleic acids through regions of substantial par-
tial complementarity? These are some of the considerations
of relevance to the therapeutic exploitation of antisense
oligonucleotides which the book fails to address. The two
chapters on triple helix forming antigene oligodeoxynucleo-
tides are intriguing in terms of the basic science involved,
although this approach offers little therapeutic prospect as
yet.
Of course, there is nothing wrong with a little fantasy to
stimulate research, but the worry is that failure of premature
and ill-conceived clinical trials might jeopardise future real-
isation of the true therapeutic potential of antisense. In terms
of the latter, 'Prospects for Antisense Nucleic Acid Therapy
of Cancer and AIDS' provides but little enlightenment.
D.M. Tidd